Axsome Therapeutics (19X.STU) Q2 2026 Earnings

4MayConfirmed
Q2 2026
-1.08
-0.96
-0.84
-0.72

Details

Expected EPS
-0.7222374489600001
Actual EPS
-1.0776906
Surprise EPS
-0.36
Surprise Percent
+49.22%

Description

Axsome Therapeutics (19X.STU) has reported earnings of -1.0776906 per share for Q2 2026.

0 Comments

Share your thoughts